Press Release: Affera : Affera Announces World's First Successful Focal Pulsed Field Ablation in Patients
WATERTOWN, Mass., Dec. 19, 2019 /PRNewswire/ -- Affera, Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today that its focal Pulsed Field ("PF") ablation technology, also known as...
Read full article »
Affera is a Massachusetts-based medical device company that manufactures and supplies products such as cardiac mapping and navigation systems for the healthcare industry.
Read more